The third National Cholesterol Education Program Adult Treatment Panel (ATP III)1 defines the metabolic (or insulin resistance) syndrome as the presence in an individual of at least three of the following five risk factors: central or abdominal obesity, hypertriglyceridemia, hypertension, low HDL cholesterol,and high fasting glucose levels. The metabolic syndrome is a major risk factor for cardiovascular disease (CVD) and type 2 diabetes. Although insulin resistance is also a key risk factor for CVD and type 2 diabetes,hyperinsulinemia is not included as a potential risk factor by the ATP III;its definition was designed for use in clinical practice with adults, and insulin levels are not usually assessed in clinical practice.

Components of the metabolic syndrome are present in children and adolescents as well as in adults,2-5 but there is no agreement on the definition of the metabolic syndrome as a whole in this population. Some researchers use definitions that follow the ATP III guidelines (having at least three or five components),6-8 whereas others have added an elevated fasting insulin level as a component of the syndrome.1 

This variability of definition is at least in part because of the growth and developmental changes that occur during childhood and adolescence and complicates the choice of cut-off points for risk factors. Norms for several of the factors, such as blood pressure, height, weight, and BMI, differ between males and females and are age-specific in that most increase normally with age.

In addition, overweight is defined differently in children than it is in adults. Because children are growing and thus changing in height and weight over time, it is not possible to provide a simple cut-point to define overweight or obesity, as is done for adults. In fact, the recent Centers for Disease Control and Prevention (CDC) definitions of overweight in children do not even use the term “obesity,” in part to avoid labeling children with a pejorative term. The preferred terms are“overweight” (defined as a BMI ≥ 95th percentile for age and sex) and “at risk of overweight” (reserved for children with a BMI≥ 85th percentile but < 95th percentile for age and sex).9 

Central obesity, considered a key component of the metabolic syndrome, is a good example of the problem of defining risk levels in children. Although there are accepted risk cut points for waist circumference in adults, there are no accepted normative values for children. Some researchers have used BMI z-score, a measure of overall overweight, rather than a more specific indicator of central overweight, such as waist circumference.7 Still others have used data from children in their studies to define age- and sex-specific percentiles, using the 90th percentile as a cut point for increased waist circumference.6  More recently, Katzmarzyk et al.10  developed risk-based, age- and sex-specific thresholds for increased waist circumference in their study of almost 3,000 African-American and white children aged 5-18 years. They used receiver operator characteristic curves to develop thresholds that predicted the presence of three or more of the other metabolic syndrome risk factors, such as low HDL cholesterol, high glucose levels, or hypertension.

Puberty presents a unique challenge to insulin-glucose homeostasis. During puberty, insulin resistance is increased, and insulin sensitivity is reduced in both nondiabetic and diabetic children. This insulin resistance is normally compensated for by increased insulin secretion.11-13 Caprio et al.12 suggested that the insulin hypersecretion they found in adolescents may reflect the puberty-associated increase in the amount of circulating growth hormone. Travers et al.14  found that changes in insulin sensitivity during puberty were sex-dependent and suggested that they are related to changes in body composition.

Body fat, blood pressure, and lipids are all affected by puberty. The percentage of body fat increases strikingly in females through adolescence,but changes in body fat in males are not consistent.15 Systolic blood pressure also rises with pubertal stage independent of age,particularly in girls.16-18 Lipids vary by pubertal stage in youth.19-21 For example, total cholesterol drops in mid-puberty and begins rising toward adult levels at the end of puberty.21,22 These lipid changes through puberty complicate the definition of cut-off points for dyslipidemia in youth. In addition, the changes in body fat, blood pressure, and lipid profiles during puberty may be influenced by the decrease in physical activity and changes in eating habits that are commonly seen during adolescence.23,24 Thus, puberty is a crucial time for the development of the metabolic syndrome,and yet it is a difficult time during which to identify it.

The prevalence of the metabolic syndrome varies by the definitions used for the components and by the weight status of the subjects. Cook et al.,6  who studied children and adolescents 12-19 years of age in the third National Health and Nutrition Examination Survey (NHANES III) data set, reported a prevalence of 4.2%. Investigators from the Bogalusa Heart Study25  reported a prevalence of 3.6% in youth 8-17 years of age. However, researchers reported much higher prevalence rates in children who are overweight or obese.6,7 In a study of 490 subjects aged 4-20 years, 89% of whom had a BMI ≥ 97th percentile, the prevalence of the metabolic syndrome in moderately obese subjects (defined as a BMI z-score of 2.0-2.5) was 38.7%, whereas almost half (49.7%) of severely obese subjects (defined as a BMI z-score > 2.5) had the syndrome.7  In another study among children and adolescents 8-19 years of age, the prevalence was 6.8% in those who were at risk for overweight (85-95th percentile of BMI)and 28.7% in those who were overweight (BMI ≥ 95th percentile).8 

The prevalence of the metabolic syndrome in youth may vary by sex and ethnicity, as it does in adults, but data on this are conflicting. In a national multiethnic study, the metabolic syndrome was significantly more prevalent in males (6.1%) than in females(2.1%),6  but other researchers reported no significant sex differences.8  Cook et al.6  reported the prevalence of the metabolic syndrome was higher in whites (4.8%) and Mexican Americans (5.6%) than in African Americans (2.0%). Weiss et al.7  also found that white children were at greater risk for metabolic syndrome than were African-American children when they used the same cut points for lipids. However, when they used race-specific norms for lipids, the prevalence of the metabolic syndrome risk did not differ between African-American and white youth, likely because the African-American youth had better lipid profiles. More large, multiethnic studies with boys and girls are needed to learn whether the ethnic and sex differences seen in the metabolic syndrome in adults are also present during childhood and adolescence.

Overweight and increased plasma insulin values are key components of the metabolic syndrome.26,27 Bao et al.27 studied > 1,500 individuals in the Bogalusa Heart Study initially when they were 5-23 years of age and then again 8 years later. They found that subjects with consistently high insulin levels had 36 times more overweight, 2.5 times more hypertension, and 3 times more dyslipidemia than those with low insulin levels. Other studies also support a link among obesity, hyperinsulinemia, and other metabolic syndrome components in youth.4,7,28 These links indicate the importance of clarifying the origins of insulin resistance while examining factors such as energy intake and output, which may be modified via diet and physical activity. Lifestyle habits certainly influence obesity and most of the metabolic syndrome components.

Not only are overweight and hyperinsulinemia associated, but the two factors are also related to dyslipidemia, especially low HDL cholesterol and high triglyceride levels.4,8,29,30 In several studies, overweight youth had higher serum insulin (with normal glucose), higher triglycerides and blood pressure, and lower HDL cholesterol than nonoverweight subjects.4,7 

Hypertension is recognized as an important component of the metabolic syndrome in adults, but its role in the syndrome in children and adolescents is not clear. Few studies of youth have examined the relationship of blood pressure and insulin values, and their results are conflicting. Some investigators found a positive association between insulin levels and blood pressure,8,31,32 whereas others have not.33,34 

Definitions of the metabolic syndrome often include impaired glucose tolerance or high fasting glucose, now called prediabetes.35 However, in several studies, overweight children had low HDL cholesterol and high triglycerides and insulin, but normal glucose levels,4,7 suggesting that glucose intolerance may develop later than other syndrome abnormalities. Thus, it may be important to assess insulin levels as well as glucose in children, because many with the cluster of metabolic syndrome factors will have normal glucose levels.

Several longitudinal studies of adults have demonstrated that hyperinsulinemia can precede the development of type 2 diabetes by > 10 years.36,37 Beck-Nielsen and Groop38  proposed a three-stage model for the development of type 2 diabetes. Stage 1 includes fasting hyperinsulinemia with normal or slightly increased blood glucose. Stage 2 is characterized by prediabetic glucose intolerance with insulin resistance, and stage 3 is development of type 2 diabetes. Unfortunately, many of the macrovascular changes associated with diabetes and related to CVD begin in stages 1 and 2, well before diagnosis. Thus, if the metabolic syndrome is identified early, the hope is that lifestyle changes can prevent the development of prediabetes or full type 2 diabetes.

Screening

Primary care providers must be aware that, as in adults, risk factors for CVD and type 2 diabetes may cluster in children and adolescents. That is,children who have one risk factor are likely to have others as well,especially if they are overweight. Early identification of children at risk will be crucial to the prevention of chronic disease during childhood and in later life.

At present, there are no guidelines for the screening and management of children or adolescents for the metabolic syndrome when defined as a separate entity, but there is guidance related to its individual components and the prevention of atherosclerosis or type 2 diabetes.39-41 The components of the metabolic syndrome and the risk factor levels that indicate increased risk are shown in Table 1.

Table 1.

Definitions of Risk for Metabolic Syndrome Components

Definitions of Risk for Metabolic Syndrome Components
Definitions of Risk for Metabolic Syndrome Components

Overweight in children is a key component of the metabolic syndrome and is recognized as a risk factor for type 2 diabetes and CVD.39,40 Childhood overweight has increased in all age groups;42  the prevalence in adolescents almost tripled during the time between the NHANES of 1971-1974 and that of 1999-2000.43  The most recent national data show that in 1999-2002, 16.0% of all children aged 6-19 were overweight; the prevalence of overweight was significantly higher in non-Hispanic black (20.5%) and Mexican-American (22.2%) than in non-Hispanic white youth(13.6%).43 

BMI is the most widely used and efficient measure of overweight in children, and age- and sex-specific norms are available for children from 2 to 20 years of age. Tables that allow for easy identification of BMI in youth are available on the CDC website at www.cdc.gov/nccdphp/dnpa/bmi/00binaries/bmi-tables.pdf,and charts for plotting a child's BMI over time may be found at www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical_charts.htm. All children should be screened yearly for overweight per recommendations of the American Academy of Pediatrics(AAP).44 

A child or adolescent who is overweight is likely to have multiple risk factors, and a thorough screening for any and all factors is necessary. Findings from an initial screening may necessitate further investigation. For example, children or adolescents with a diagnosis of hypertension will need to be screened for secondary causes of hypertension. The appropriate screening for secondary comorbidities in children is detailed in a recent report by the National High Blood Pressure Program (NHBPP) Working Group.45  A link to the reference is available online at www.nhlbi.nih.gov/health/prof/heart/hbp/hbp_ped.htm.

Biennial screening for diabetes with a fasting plasma glucose is recommended by the American Diabetes Association35  for children who are either overweight or at risk for overweight (≥ 85th percentile for age and sex) and have at least two of the following risk factors: family history of type 2 diabetes in first- and second-degree relatives; membership in certain race/ethnic groups (Native Americans, African Americans, Hispanic Americans, Asians/South Pacific Islanders); and signs of insulin resistance or conditions associated with insulin resistance(acanthosis nigricans, hypertension, dyslipidemia, polycystic ovary syndrome). This testing should begin by the age of 10 years, or sooner if puberty has already begun.

American Heart Association (AHA) recommendations add the assessment of fasting insulin to the evaluation of children at risk for insulin resistance.40  The AAP Expert Committee on Evaluation and Treatment of Obesity in Children recommends measurement of both fasting glucose and insulin.41  In addition, measurement of glucose and insulin may also be warranted in girls who enter puberty early. Girls with early menarche tend to have excess body fat and higher insulin starting in early childhood and have a higher prevalence of the metabolic syndrome in young adulthood.46 

Children with a family history of early CVD or parental hypercholesterolemia (≥ 240 mg/dl) should be tested for dyslipidemias including low HDL cholesterol, high LDL cholesterol, and hypertriglyceridemia with a fasting lipid profile per AHA recommendations.40 In addition, the AHA recommends screening for children with any of the following conditions: “hypertension, smoking, sedentary lifestyle,obesity, excessive alcohol intake,... medications associated with hyperlipidemias... or disease states such as diabetes mellitus or nephritic syndrome.” Similar recommendations have been made by the AAP Expert Committee.41 

Finally, children who are overweight must also be screened for hypertension. The NHBPP Working Group45  recommends blood pressure screening for all children > 3 years of age at all medical visits. A cuff of appropriate size should be used for measuring blood pressure in children. The recommendations state that the appropriate cuff has “an inflatable bladder width of 40% of the arm circumference at a point midway between the olecranon and the acromion” and “the cuff bladder length should cover 80-100% of the circumference of the arm.”

As in adults, elevated blood pressure on three separate occasions is necessary for diagnosis of prehypertension or hypertension. Cut points for prehypertension and hypertension in children are found in Table 1. In addition, the NHBPP Working Group45 recommends that overweight children with prehypertension and all children with hypertension be screened with a lipid profile and fasting glucose because of the probability of risk factor clustering.

Management and Prevention

Ten and McLaren47  state that “attention must be urgently given to the children who are becoming more obese and more insulin resistant with time.” Currently, there are no practice guidelines for management of the metabolic syndrome in children,but recommendations exist for management of components of the syndrome.

The AAP Expert Committee41  has outlined goals for childhood weight maintenance or loss that are dependent on the child's age and weight and the presence of any secondary complications. It recommends that children ≤ 7 years of age with a BMI ≥ 95th percentile for age and sex maintain their weight unless they have secondary complications, such as hypertension; it recommends weight loss to ≤ 85th percentile for those with secondary complications. Weight loss is also recommended for older children who have a BMI “between the 85 and 95th percentile and a nonacute secondary complication of obesity” and for any child > 7 years of age with a BMI ≥ 95th percentile. Lifestyle changes in diet, physical activity, and sedentary activity are recommended as first-line therapy for overweight, hypertension, insulin resistance, and dyslipidemia by several expert authors.40,41,45 

Physical inactivity fosters the development of obesity, the metabolic syndrome abnormalities,48,49 and diabetes.50,51 Exercise can improve responses to a 2-hour glucose tolerance test52  and improve insulin sensitivity even without weight loss,53  apparently through activation of cellular glucose uptake independent of insulin.54  Several recent studies have shown that physical activity is also associated with lower fasting insulin and greater insulin sensitivity in children.55,56 Exercise can also improve blood pressure, both directly and by increasing insulin sensitivity.57 

Fewer studies have reported the association of cardiovascular fitness with the metabolic syndrome in adults or youth. In their study of ∼ 1,500 youth aged 8-15 years, Ribeiro et al.58  found that male children and adolescents in the lowest quartile for physical activity had more metabolic syndrome risk factors, such as high blood pressure and hypercholesterolemia.

Recommendations for dietary intake in children and adolescents include consumption of at least five fruits and vegetables a day; increased consumption of whole grains; avoidance of sweets, sodas, and other empty-calorie foods; and a dietary fat content of no more than 30% of total calories per day. These guidelines are available online at www.health.gov/dietaryguidelines/dga2000/document/frontcover.htm.

Unfortunately, studies verify that the diet of adolescents is poor.59-61 A longitudinal study of children 6-13 years of age showed that drinking excessive amounts of sweetened drinks (defined as > 12 oz/day) was associated with a higher daily energy intake, greater weight gain, and displacement of milk from the diet.60 Investigators in England reported that a school-based program to decrease the consumption of carbonated beverages was successful in producing a small reduction in the amount of consumption of these drinks and was associated with a reduction in the number of overweight children.61  The AAP issued a statement in January 2004 expressing concern over the negative health implications of providing soft drinks in schools. It recommended that school districts adopt a “clearly defined, district-wide policy that restricts the sale of soft drinks.”62 

The AAP Expert Committee41 provides a comprehensive summary of strategies for helping families of overweight children and stresses the need for health professionals to assess the parents' and adolescents' readiness to participate in lifestyle changes or treatment. The strategies include suggestions for helping parents develop parenting skills that promote healthy eating behaviors in children and ideas for increasing physical activity for children and families, such as walking to school or decreasing time spent watching television.

Suggestions are also provided to promote dietary change, for example, use of the “stoplight diet” developed by Epstein and Squires.63  In this dietary plan, children and families may choose foods from three categories that correspond to the three colors on a stoplight: “green” foods may be eaten anytime; “yellow” foods are to be consumed less often; and “red” foods should be avoided. Families may also benefit from referral to a registered dietitian for more in-depth dietary counseling.

Guidelines are also available that go beyond encouragement for lifestyle change. The AHA Expert Committee recommends a diet low in saturated fat and cholesterol for the initial management of childhood hypercholesterolemia, but it also advises referral to physicians with experience managing lipid disorders in children for children whose cholesterol levels remain elevated.40 Medications for children with hypercholesterolemia may include bile acid sequestrants, such as cholestyramine or cholestipol,41  and research on the use of statins for more severe familial hypercholesterolemia is promising.64,65 The management of hypertension in children and adolescents is described in detail by the NHBPP Working Group.45  Other than encouragement of increased physical activity and healthy dietary choices, and careful monitoring for related complications, there are no currently accepted recommendations for the management of increased glucose levels and hyperinsulinemia in children who are otherwise well. An exception would be the child with a fasting glucose measure that is indicative of diabetes (> 126 mg/dl). This child should be referred to the care of a pediatric endocrinologist.41 Children with multiple components of the metabolic syndrome may benefit from referral to specialists who have experience with the management of obesity,hypertension, dyslipidemia or insulin resistance.40 

The best approach to decreasing the incidence of metabolic syndrome in children may be prevention.40,45,66 Primary care providers can encourage children, adolescents, and their parents to adopt lifestyle changes such as healthier diets, increased physical activity, and decreased sedentary activities. For example, parents can be encouraged to simply decrease the time their children and adolescents spend watching TV. Dennison et al.67  found that in children, both increased TV watching and the presence of a TV in the bedroom is associated with an increased risk of having a BMI ≥ 85th percentile for age and sex. In addition, watching TV while eating meals has been associated with a less nutritious dietary intake in children.68 

Primary care providers can also help in the effort to prevent obesity in children by supporting public policy changes that promote increased physical activity, such as the planning of neighborhoods that provide safe activity areas and increases in physical education (PE) time in schools. Decreased neighborhood safety is associated with decreased physical activity in children.69  PE programs in schools provide a mechanism for reaching a great number of children on a daily basis to promote increased physical activity and to provide education on healthier lifestyle choices. Programs that provide health education and modify PE in elementary and middle schools to increase noncompetitive physical activity and decrease down time have been shown to improve fitness and cardiovascular risk profiles,70,71 but few schools provide daily PE. Only 6.4% of middle schools and 5.8% of high schools provided such an opportunity in one nationwide study.72 

At present, the metabolic syndrome is found in ∼ 4-5% of children and adolescents in population-based studies,6  and in up to 49% of severely obese youth.7  This presents a serious threat to the current and future health of American youth. The metabolic syndrome and its many consequences, including CVD and type 2 diabetes, will continue to increase unless we can find ways to prevent obesity and the metabolic syndrome in childhood and adolescence.

We must be diligent in screening for and identifying children and adolescents with metabolic syndrome and supporting and encouraging them and their families through healthy lifestyle changes. Primary care providers can join other health care providers in developing and testing primary prevention strategies that will change the environment to provide access to safe places where our children can be active and play and to promote an atmosphere conducive to making healthier food choices.

Editor's note: The information presented here is also the subject of a separate article which the authors have submitted for publication elsewhere.

Ann Jessup, MSN, RN, APRN, BC, is a doctoral student, and Joanne S. Harrell, PhD, RN, FAAN, FAHA, is the Frances Hill Fox Professor of Nursing at the University of North Carolina at Chapel Hill School of Nursing.

1
Ford ES, Giles WH:A comparison of the prevalence of the metabolic syndrome using two proposed definitions.
Diabetes Care
26
:
575
-581,
2003
2
Jiang X,Srinivasan SR, Webber LS, Wattigney WA, Berenson GS: Association of fasting insulin level with serum lipid and lipoprotein levels in children,adolescents, and young adults: the Bogalusa Heart Study.
Arch Intern Med
155
:
190
-196,
1995
3
Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV: Co-existence of severe insulin resistance and hyperinsulinaemia in preadolescent obese children.
Diabetologa
39
:
1489
-1497,
1996
4
Mo-Suwan L, Lebel L: Risk factors for cardiovascular disease in obese and normal school children: association of insulin with other cardiovascular risk factors.
Biomed Environ Sci
9
:
269
-275,
1996
5
Arslanian S,Suprasongsin C: Insulin sensitivity, lipids, and body composition in childhood: Is syndrome x present?
J Clin Endocrinol Metab
81
:
1058
-1062,
1996
6
Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.
Arch Pediatr Adolesc Med
157
:
821
-827,
2003
7
Weiss R, Dziura J,Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M,Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents.
N Engl J Med
350
:
2362
-2374,
2004
8
Cruz ML,Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI: The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
J Clin Endocrinol Metab
89
:
108
-113,
2004
9
Centers for Disease Control and Prevention: BMI for children and teens. 8 April 2003. Available at: http://www.cdc.gov/nccdphp/dnpa/bmi/bmi-for-age.htm. Accessed 27 August 2004
10
Katzmarzyk P,Srinivasan S, Wei C, Malina R, Bouchard C, Berenson G: Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents.
Pediatrics
114
:
E198
-E205,
2004
11
Bloch CA, Clemons P, Sperling MA: Puberty decreases insulin sensitivity.
J Pediatr
110
:
481
-487,
1987
12
Caprio S, Plewe G,Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV: Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity.
J Pediatr
114
:
963
-967,
1989
13
Cook JS, Hoffman RP, Stene MA, Hansen JR: Effects of maturational stage on insulin sensitivity during puberty.
J Clin Endocrinol Metab
77
:
725
-730,
1993
14
Travers SH,Jeffers BW, Bloch CA, Hill JO, Eckel RH: Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children.
J Clin Endocrinol Metab
80
:
172
-178,
1995
15
Irwin CE: Somatic growth and development during adolescence. In
Pediatrics
. Rudolph AM, Ed. East Norwalk, Conn.,Appleton & Lange,
1991
, p.
39
16
Weir MR, Stafford EM, Gregory G, Lawson MA, Pearl W: The relationship between sexual maturity rating, age, and increased blood pressure in adolescents.
J Adolesc Health Care
9
:
465
-469,
1988
17
Kozinetz CA:Sexual maturation and blood pressure levels of a biracial sample of girls.
Am J Dis Child
145
:
142
-147,
1991
18
Bradley CB,Harrell JS, McMurray RG, Bangdiwala SI, Frauman AC, Webb JS: The prevalence of high cholesterol, hypertension, and smoking in N.C. elementary school-aged children.
N C Med J
58
:
362
-367,
1997
19
Webber LS, Harsha DW, Phillips GT, Srinivasan SR, Simpson JW, Berenson GS: Cardiovascular risk factors in Hispanic, white, and black children: the Brooks County and Bogalusa Heart Studies.
Am J Epidemiol
133
:
704
-714,
1991
20
Belcher JD,Ellison RC, Shepard WE, Bigelow C, Webber LS, Wilmore JH, Parcel GS, Zucker DM, Luepker RV: Lipid and lipoprotein distributions in children by ethnic group, gender, and geographic location—preliminary findings of the Child and Adolescent Trial for Cardiovascular Health (CATCH).
Prev Med
22
:
143
-153,
1993
21
Berenson GS,Srinivasan SR, Cresanta JL, Foster TA, Webber LS: Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation.
Am J Epidemiol
113
:
157
-170,
1981
22
Boulton TJ,Magarey AM, Cockington RA: Serum lipids and apolipoproteins from 1 to 15 years: changes with age and puberty, and relationships with diet, parental cholesterol and family history of ischaemic heart disease.
Acta Paediatr
84
:
1113
-1118,
1995
23
Hill JO,Trowbridge FL: Childhood obesity: future directions and research priorities.
Pediatrics
101
:
570
-574,
1998
24
Sallis JF,Simons-Morton BG, Stone EJ, Corbin CB, Epstein LH, Faucette N, Iannotti RJ,Killen JD, Klesges RC, Petray CK: Determinants of physical activity and interventions in youth.
Med Sci Sports Exerc
24
:
S248
-S257,
1992
25
Srinivasan S,Meyers, Berenson G: Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study.
Diabetes
51
:
204
-209,
2002
26
Reaven GM:Pathophysiology of insulin resistance in human disease.
Physiol Rev
75
:
473
-486,
1995
27
Bao W, Srinivasan SR, Berenson GS: Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults.
Circulation
93
:
54
-59,
1996
28
Weiss R, Dufour S,Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G,Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S:Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.
Lancet
362
:
951
-957,
2003
29
Arslanian S,Suprasongsin C: Insulin sensitivity, lipids, and body composition in childhood: is syndrome x present?
J Clin Endocrinol Metab
81
:
1058
-1062,
1996
30
Steinberger J,Moorehead C, Katch V, Rocchini AP: Relationship between insulin resistance and abnormal lipid profile in obese adolescents.
J Pediatr
126
:
690
-695,
1995
31
Raitakari OT,Porkka KVK, Ronnemaa T, Knip M, Uhari M, Akerblom HK, Viikari JS: The role of insulin in clustering of serum lipids and blood pressure in children and adolescents.
Diabetologia
38
:
1042
-1050,
1995
32
Cruz ML, Huang TT,Johnson MS, Gower BA, Goran MI: Insulin sensitivity and blood pressure in black and white children.
Hypertension
40
:
18
-22,
2002
33
Bergstrom E,Hernell O, Persson LA, Vessby B: Insulin resistance syndrome in adolescents.
Metabolism
45
:
908
-914,
1996
34
Berenson GS,Radhakrishnamurthy B, Srinivasan SR, Voors AW, Foster TA, Dalferes ER Jr,Webber LS: Plasma glucose and insulin levels in relation to cardiovascular risk factors in children from a biracial population: the Bogalusa Heart Study.
J Chron Dis
34
:
379
-391,
1981
35
American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement).
Diabetes Care
27
(Suppl. 1):
S5
-S10,
2004
36
Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.
Lancet
340
:
925
-929,
1992
37
Zimmet PZ, Collins VR, Dowse GK, Knight LT: Hyperinsulinaemia in youth is a predictor of type 2(non-insulin-dependent) diabetes mellitus.
Diabetologia
35
:
534
-541,
1992
38
Beck-Nielsen H,Groop LC: Metabolic and genetic characterization of prediabetic states:sequence of events leading to non-insulin-dependent diabetes mellitus.
J Clin Invest
94
:
1714
-1721,
1994
39
American Diabetes Association:Prevention or delay of type 2 diabetes (Position Statement).
Diabetes Care
27
(Suppl. 1):
S47
-S54,
2004
40
Williams CL,Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, Bazzarre T:Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young(AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association.
Circulation
106
:
143
-160,
2002
41
Barlow SE, Dietz WH: Obesity evaluation and treatment: Expert Committee recommendations: the Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services.
Pediatrics
102
:
E29
,
1998
42
Ogden, CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among U.S. children and adolescents, 1999-2000.
JAMA
288
:
1728
-1732,
2002
43
Hedley, AA, Ogden,CL, Johnson, CL, Carroll, MD, Curtin, LR, Flegal, KM: Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999-2002.
JAMA
291
:
2847
-2850,
2004
44
American Academy of Pediatrics Committee on Nutrition: Prevention of pediatric overweight and obesity.
Pediatrics
112
:
424
-430,
2003
45
National High Blood Pressure Education Working Group: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.
Pediatrics
114
:
555
-576,
2004
46
Centers for Disease Control and Prevention: CDC table for calculated body mass index values for selected heights and weights for ages 2 to 20 years. Available online at www.cdc.gov/nccdphp/dnpa/bmi/00binaries/bmi-tables.pdf. Accessed 27 August 2004
47
Ten S, McLaren N:Insulin resistance syndrome in children.
J Clin Endocrinol Metab
89
:
2526
-2539,
2004
48
Anderson RE,Crespo CJ, Bartlett SJ, Cheskin LJ, Pratt M: Relationship of physical activity and television watching with body weight and level of fatness among children.
JAMA
279
:
938
-942,
1998
49
Laaksonen DE,Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA: Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.
Diabetes Care
25
:
1612
-1618,
2002
50
Burchfiel CM,Sharp DS, Curb JD, Rodriguez BL, Hwang LJ, Marcus EB, Yano K: Physical activity and incidence of diabetes: the Honolulu Heart Program.
Am J Epidemiol
141
:
360
-368,
1995
51
Dowse GK, Zimmet PZ, Gareeboo H, George K, Alberti MM, Tuomilehto J, Finch CF, Chitson P,Tulsidas H: Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians.
Diabetes Care
14
:
271
-282,
1991
52
Saltin B,Lindgarde F, Houston M, Horlin R, Nygaard E, Gad P: Physical training and glucose tolerance in middle-aged men with chemical diabetes.
Diabetes
28
:
30
-32,
1979
53
Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW: Exercise training,without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults.
Diabetes Care
26
:
557
-562,
2003
54
Houmard JA, Egan PC, Neufer PD, Friedman JE, Wheeler WS, Israel RG, Dohm GL: Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men.
Am J Physiol
261
:
E437
-E443,
1991
55
Kang HS, Gutin B,Barbeau P, Owens S, Lemmon CR, Allison J, Litaker MS, Le NA: Physical training improves insulin resistance syndrome markers in obese adolescents.
Med Sci Sports Exerc
34
:
1920
-1927,
2002
56
Schmitz KH, Jacobs DR Jr, Hong CP, Steinberger J, Moran A, Sinaiko AR: Association of physical activity with insulin sensitivity in children.
Int J Obes Relat Metab Disord
26
:
1310
-1316,
2002
57
Shoemaker JK,Bonen A: Vascular actions of insulin in health and disease.
Can J Appl Physiol
20
:
127
-154,
1995
58
Ribeiro JC, Guerra S, Oliveira J, Teixeira-Pinto A, Twisk JW, Duarte JA, Mota J: Physical activity and biological risk factors clustering in pediatric population.
Prev Med
39
:
596
-601,
2004
59
Mannino ML, Lee Y,Mitchell DC, Smiciklas-Wright H, Birch LL: The quality of girls' diets declines and tracks across middle childhood.
Int J Behav Nutr Phys Act
1
:
1
-11,
2004
60
Mrdjenovic G,Levitsky DA: Nutritional and energetic consequences of sweetened drink consumption in 6- to 13-year-old children.
J Pediatr
142
:
604
-610,
2003
61
James J, Thomas P,Cavan D, Kerr D: Preventing childhood obesity by reducing consumption of carbonated drinks: cluster randomised controlled trial.
BMJ
328
:
1237
,
2004
62
American Academy of Pedatrics: Soft drinks in schools.
Pediatrics
113
:
152
-154,
2004
63
Epstein L, Squires S:
The Stoplight Diet for Children
. Boston, MA,Little, Brown and Company,
1988
64
McCrindle BW,Helden E, Cullen-Dean KG, Conner WT: A randomized crossover trial of combination pharmacologic therapy in children with familial hypercholesterolemia.
Pediatric Res
51
:
715
-721,
2002
65
Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Buller HR, Sijbrands EJ, Kastelein JJ:Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
JAMA
292
:
331
-337,
2004
66
AAP Committee on Nutrition: Prevention of pediatric overweight and obesity.
Pediatrics
112
:
424
-430,
2003
67
Dennison BA, Erb TA, Jenkins PL: Television viewing and television in bedroom associated with overweight risk among low-income pre-school children.
Pediatrics
109
:
1028
-1035
2002
68
Coon KA, Goldberg J, Rogers BL, Tucker KL: Relationships between use of television during meals and children's food consumption patterns.
Pediatrics
107
:
E7
,
2001
69
Molnar BE,Gortmaker SL, Bull FC, Buka SL: Unsafe to play? Neighborhood disorder and lack of safety predict reduced physical activity among urban children and adolescents.
Am J Health Promot
18
:
378
-386
2004
70
Harrell JS,McMurray RG, Gansky SA, Bangdiwla SI, Frauman AG, Bradley CB: A public health versus a risk-based intervention to improve cardiovascular health in elementary school children: the Cardiovascular Health in Children (CHIC)study.
Am J Public Health
89
:
1529
-1535,
1999
71
McMurray RG,Harrell JS, Bangdiwala SI, Bradley CB, Deng S, Levine A: A school-based intervention can reduce body fat and blood pressure in young adolescents.
J Adoles Health
31
:
125
-132,
2002
72
Kolbe LJ, Kann L,Brener ND: Overview and summary of findings: School Health Policies and Programs Study 2000.
J Sch Health
71
:
253
-259,
2001
73
National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Cholesterol and atherosclerosis in children. 2004. Available online at: http://www.americanheart.org/presenter.jhtml?identifier=4499. Accessed 20 July 2004